Mark F. Kubik BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology...
Therapeutics
Akari Therapeutics (NASDAQ: AKTX) has appointed Mark F. Kubik as Head of...
April 22, 2025 7:17 AM EDT | Source: Bleichmar Fonti & Auld New York, New York--(Newsfile Corp. - April...
Friday, June 7, 2024TOPICS: AlumniJohn HealySAN DIEGO (June 7, 2024) – University of San Diego (USD) School of Law alumnus...
